LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression
出版年份 2020 全文链接
标题
LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression
作者
关键词
-
出版物
Molecular Cancer
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-30
DOI
10.1186/s12943-020-01217-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling
- (2020) Jiarong Chen et al. CANCER LETTERS
- Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer
- (2019) Shuai Yuan et al. Molecular Oncology
- Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1
- (2019) Gaoxiang Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer
- (2019) Katharina Kriegsmann et al. PATHOLOGY
- Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling
- (2019) Hongyu Guan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
- (2019) Jie Xu et al. CANCER RESEARCH
- Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression
- (2019) Fanrui Zeng et al. ONCOGENE
- The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients
- (2019) Bing-Yen Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer
- (2018) Chang Li et al. CANCER LETTERS
- Antiangiogenic therapies in non-small-cell lung cancer
- (2018) A. Alshangiti et al. Current Oncology
- Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma
- (2018) Yong Wang et al. Molecular Cancer
- miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways
- (2018) Xin Zhang et al. Molecular Therapy-Nucleic Acids
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis
- (2018) Di Wu et al. CANCER LETTERS
- Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer
- (2018) Weiwei Yu et al. ONCOGENE
- LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
- (2018) Changhao Chen et al. Nature Communications
- The positive feedback between lncRNA TNK2-AS1 and STAT3 enhances angiogenesis in non-small cell lung cancer
- (2018) Yue Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer
- (2017) Jean-Charles Soria et al. EUROPEAN JOURNAL OF CANCER
- VEGF as a potential target in lung cancer
- (2017) Daniela Frezzetti et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- miR-150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma
- (2017) Xiangyong Li et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review
- (2017) Margo M. Jacobsen et al. LUNG CANCER
- Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression
- (2017) Binyao Yang et al. Molecular Cancer
- Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells
- (2017) Xin Zhang et al. Molecular Cancer
- JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework
- (2017) Aziz Khan et al. NUCLEIC ACIDS RESEARCH
- Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC
- (2017) Junchao Cai et al. Nature Communications
- Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non–Small Cell Lung Cancer Patients
- (2016) Razelle Kurzrock et al. CLINICAL CANCER RESEARCH
- A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A
- (2016) Kazuhiro Usui et al. LUNG CANCER
- Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells
- (2015) Daniela Frezzetti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- YuGene: A simple approach to scale gene expression data derived from different platforms for integrated analyses
- (2014) Kim-Anh Lê Cao et al. GENOMICS
- Nkx2-8 Downregulation Promotes Angiogenesis and Activates NF- B in Esophageal Cancer
- (2013) C. Lin et al. CANCER RESEARCH
- Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
- (2013) Sampurna Chatterjee et al. JOURNAL OF CLINICAL INVESTIGATION
- A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer
- (2013) T. Ciuleanu et al. LUNG CANCER
- In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
- (2011) Florian A. Karreth et al. CELL
- Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients
- (2010) Pierpaolo Correale et al. CANCER BIOLOGY & THERAPY
- Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
- (2010) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer
- (2010) John D. Hainsworth et al. Journal of Thoracic Oncology
- Quantitative and morphometric evaluation of the angiogenic effects of leptin
- (2008) Dodanim Talavera-Adame et al. JOURNAL OF BIOMEDICAL OPTICS
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started